SANARA MEDTECH INC (SMTI) Stock Price, Quote, News and Overview
NASDAQ:SMTI - Nasdaq - US79957L1008 - Common Stock - Currency: USD
SMTI Quote, Performance and Key Statistics
NASDAQ:SMTI (8/15/2025, 11:17:09 AM)
29.72
-0.68 (-2.24%)
The current stock price of SMTI is 29.72 USD. In the past month the price increased by 10.71%. In the past year, price decreased by -6.26%.
SMTI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.12 | 43.66B | ||
| COO | COOPER COS INC/THE | 18.92 | 14.64B | ||
| SOLV | SOLVENTUM CORP | 11.9 | 12.52B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.3 | 10.44B | ||
| BLCO | BAUSCH + LOMB CORP | 34.94 | 5.19B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.22 | 5.02B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.37 | 3.70B | ||
| ICUI | ICU MEDICAL INC | 16.09 | 2.98B | ||
| XRAY | DENTSPLY SIRONA INC | 8.13 | 2.77B | ||
| HAE | HAEMONETICS CORP/MASS | 11.31 | 2.53B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.72 | 1.71B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.41B |
Related stock screener links
About SMTI
Company Profile
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 141 full-time employees. The company markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.
Company Info
SANARA MEDTECH INC
1200 Summit Avenue, Suite 414
Fort Worth TEXAS 76102 US
CEO: Ronald T. Nixon
Employees: 108
Phone: 18175292300
SANARA MEDTECH INC / SMTI FAQ
What is the stock price of SANARA MEDTECH INC today?
The current stock price of SMTI is 29.72 USD. The price decreased by -2.24% in the last trading session.
What is the ticker symbol for SANARA MEDTECH INC stock?
The exchange symbol of SANARA MEDTECH INC is SMTI and it is listed on the Nasdaq exchange.
On which exchange is SMTI stock listed?
SMTI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SANARA MEDTECH INC stock?
8 analysts have analysed SMTI and the average price target is 49.98 USD. This implies a price increase of 68.17% is expected in the next year compared to the current price of 29.72. Check the SANARA MEDTECH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SANARA MEDTECH INC worth?
SANARA MEDTECH INC (SMTI) has a market capitalization of 264.21M USD. This makes SMTI a Micro Cap stock.
How many employees does SANARA MEDTECH INC have?
SANARA MEDTECH INC (SMTI) currently has 108 employees.
What are the support and resistance levels for SANARA MEDTECH INC (SMTI) stock?
SANARA MEDTECH INC (SMTI) has a resistance level at 30.41. Check the full technical report for a detailed analysis of SMTI support and resistance levels.
Is SANARA MEDTECH INC (SMTI) expected to grow?
The Revenue of SANARA MEDTECH INC (SMTI) is expected to grow by 20.98% in the next year. Check the estimates tab for more information on the SMTI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SANARA MEDTECH INC (SMTI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SMTI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SMTI, evaluating the profitability, health, valuation and growth aspects
- SANARA MEDTECH INC (SMTI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SANARA MEDTECH INC (SMTI) Sales and EPS estimates to see what analysts future expectations are.
- SANARA MEDTECH INC (SMTI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SANARA MEDTECH INC (SMTI) Insider and Institutional Ownership to learn about the owners and their transactions.
- SANARA MEDTECH INC (SMTI) Stock Chart to make your own analysis
- SANARA MEDTECH INC (SMTI) Latest news and press-releases to stay up to date.
Does SANARA MEDTECH INC (SMTI) stock pay dividends?
SMTI does not pay a dividend.
When does SANARA MEDTECH INC (SMTI) report earnings?
SANARA MEDTECH INC (SMTI) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of SANARA MEDTECH INC (SMTI)?
SANARA MEDTECH INC (SMTI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.16).
What is the Short Interest ratio of SANARA MEDTECH INC (SMTI) stock?
The outstanding short interest for SANARA MEDTECH INC (SMTI) is 7.82% of its float. Check the ownership tab for more information on the SMTI short interest.
SMTI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to SMTI. When comparing the yearly performance of all stocks, SMTI is a bad performer in the overall market: 76.05% of all stocks are doing better.
SMTI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SMTI. While SMTI seems to be doing ok healthwise, there are quite some concerns on its profitability.
SMTI Financial Highlights
Over the last trailing twelve months SMTI reported a non-GAAP Earnings per Share(EPS) of -1.16. The EPS decreased by -48.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.86% | ||
| ROE | -31.16% | ||
| Debt/Equity | 1.18 |
SMTI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to SMTI. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -39.58% and a revenue growth 20.98% for SMTI